Here are five points:
1. Dr. Klamerus has served as interim president of the hospital since April 2016.
2. He has previously served in a number of leadership roles at Karmanos, which was acquired by Flint, Mich.-based McLaren Health Care in 2014, including as executive vice president/chief quality officer.
3. He completed a fellowship in medical oncology from Baltimore-based Johns Hopkins University.
4. He is a member of the American Society of Clinical Oncology as well as the Steering Committee of the Michigan Oncology Quality Consortium.
5. In his new role, Dr. Klamerus will oversee all clinical operations at Karmanos’ treatment locations in Detroit and Farmington Hills, Mich.
More articles on healthcare executive moves:
Sparks Health names Shane Knisley COO: 3 things to know
St. Joseph’s Health taps Leslie Paul Luke to lead as CEO: 4 notes
Michael Henze to retire after 27 years as Lake Regional Health System CEO
